Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page. This appears to be a frontend metadata update with no changes to study content or eligibility.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.4.3 is now shown on the page, replacing v3.4.2.SummaryDifference0.1%

- Check55 days agoChange DetectedAddition of Revision: v3.4.2 and deletion of government funding/outage notices (Revision: v3.4.1); these are site-wide maintenance updates and do not alter trial-specific content.SummaryDifference0.4%

- Check62 days agoChange DetectedSite-wide government funding notice was added and the page revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange DetectedMinor UI/metadata updates were implemented, such as Show glossary and revision/version label changes (v3.4.0; No FEAR Act Data; Last Update Submitted that Met QC Criteria), with core study content unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedThe page now displays a new revision note 'Revision: v3.3.4' and the previous 'Revision: v3.3.3' note was removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.